Daratumumab plus Cyclophosphamide, Bortezomib and Dexamethasone (Dara-CyBorD) in Previously Untreated and Relapsed Subjects with Multiple Myeloma

Type of Cancer
Multiple Myeloma

Site
Bethesda

Protocol Number
54767414MMY2012

To Learn More Call
201-510-0910